Allopurinol

Description

Allopurinol is a xanthine-oxidase inhibitor. Allopurinol and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid.

Medicine classification

ATC Code
Title
Class
M04AA01
Allopurinol
M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production

Medicines

Drug
Countries
ACEPURIN

Netherlands

ADENO

Hong Kong

ALLNOL

Hong Kong

ALLOPIN

Hong Kong

ALLOPRANOL

Hong Kong

ALLOSIG

Australia

ALLOSTAD

Austria

ALOPRIM

United States

ALOPRON

Cyprus

ENPUROL

Hong Kong

ESLORIC

Hong Kong

GICHTEX RETARD

Austria

MILURIT

Lithuania

PROGOUT

Australia

PURIDE

Hong Kong

PURINOL

Austria

SYNORID

Hong Kong

SYNPURINOL

Hong Kong

URICTO

United Kingdom

UROSIN

Austria Singapore

ZYLAPOUR

Cyprus

ZYLOPRIM

Australia Canada United States

ZYLORIC

Austria Cyprus France Hong Kong Netherlands

Other medications with this active ingredient in combination: DUZALLO

Product monographs

Monograph
Type
Country
ZYLOPRIM Tablet
MPI, US: SPL/Old
US
ZYLORIC Tablet
MPI, EU: SmPC
UK

2D Molecule Structure

2D representation of molecule

Unique Ingredient Identifier (UNII)

63CZ7GJN5I - ALLOPURINOL

CAS Registry Number

315-30-0 - allopurinol

SNOMED-CT

387135004 - Allopurinol (substance)

Usage: Next >